Citation

Amit BH, Caddy C, Mccloud TL, Rendell JM, Hawton K, Diamond PR, McShane R, Cipriani A. Cochrane Database Syst. Rev. 2015; 2015(4).

Copyright

(Copyright © 2015, The Cochrane Collaboration, Publisher John Wiley and Sons)

DOI

10.1002/14651858.CD011612

PMID

unavailable

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: to assess the effects of ketamine and other glutamate receptor modulators in alleviating the acute symptoms of depression in people with unipolar major depressive disorder to review the acceptability of ketamine and other glutamate receptor modulators in people with unipolar major depressive disorder to investigate the adverse effects of ketamine and other glutamate receptor modulators in people with unipolar major depressive disorder © 2015 The Cochrane Collaboration.

Language: en

Keywords

human; cognition; suicide; systematic review; quality of life; ketamine; suicidal ideation; depression; suicide attempt; major depression; hope; dextromethorphan; priority journal; health care cost; tramadol; drug efficacy; drug tolerability; remission; amantadine; cycloserine; atomoxetine; Montgomery Asberg Depression Rating Scale; Article; Clinical Global Impression scale; glutamate receptor antagonist; riluzole; memantine; quinolinic acid; Hamilton Depression Rating Scale; social acceptance; deaths by suicide; lanicemine; rapastinel; rislenemdaz